Trenbolone Acetate
Tren A · Fina
Short-acting 19-nor ester requiring every-other-day dosing. Simple model — peak calibrated.
Key takeaways
- Short-acting trenbolone ester — ~1.5-day half-life, so every-other-day or daily injection is standard.
- Veterinary compound (Finaplix); never approved for humans, so all use data is anecdotal.
- No aromatization, but cardiovascular strain, renal stress, and psychological effects are the main concerns.
- Fast clearance is its main advantage — side effects resolve within days of stopping, not weeks.
Overview
What it is
Trenbolone acetate is the short-acting ester of trenbolone, the 19-nor androgen originally formulated as Finaplix cattle implants. It binds the androgen receptor at roughly three times testosterone's affinity, drives nitrogen retention and protein synthesis aggressively, and neither aromatizes nor 5-alpha-reduces. It was never approved for human use.
Pharmacokinetics
The ~1.5-day half-life is the defining feature: serum levels swing fast, so community protocols inject every other day or daily to hold levels flat. The short ester also means rapid clearance if side effects appear, which is the main argument for acetate over longer trenbolone esters.
Harm reduction
Priorities mirror the other trenbolone esters — blood pressure, lipids, kidney markers, and psychological effects — plus an acute post-injection cough reported with some shots. Hepatotoxicity is rated mild and HPTA suppression is severe and rapid. Human evidence is anecdotal; the curve is a calibrated model.
Reported dosing protocols
Protocols reported in research literature and clinic/community use — informational context, not a dosing recommendation.
| Use case | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Performance (community) | 35–100 mg | IM | Daily or EOD | 6–10 weeks |
Pharmacokinetic summary
- Model tier
- Simple (t½ + F, Tmax estimated)
- Half-life
- 36 hours
- Cmax
- 68.9 ng/dL
- Bioavailability
- 87%
- Typical dose
- 35–100 mg
Harm reduction
- Aromatizes
- No
- DHT derivative
- No
- Hepatotoxicity
- mild
- Injection frequency
- EOD–daily
⚠ Trenbolone + PDE5 inhibitors (e.g. tadalafil) raises risk of cardiovascular strain.
Frequently asked questions
Why is acetate the most common trenbolone ester?
The ~1.5-day half-life means the compound clears within days of the last injection. If blood pressure, sleep, or psychological side effects become unmanageable, they resolve fast — with enanthate the wait stretches to weeks. The cost is every-other-day or daily injection.
What is "tren cough"?
An acute coughing fit reported within minutes of some trenbolone injections, likely from oil or solvent reaching the bloodstream. It is brief and self-limiting but alarming, and it gets reported most often with acetate because of the injection frequency.
Is trenbolone detectable in drug tests?
Yes. Anti-doping labs screen for the epitrenbolone glucuronide metabolite by LC-MS/MS, with a controlled-study detection ceiling around 1 month for the acetate ester.
References
- Trenbolone ester PK — Cmax calibrated to ng/dL serum peak.
- Trenbolone ester PK / metabolism study — Source of the ester PK values behind the calibrated curve.
Related compounds
Trenbolone Enanthate
Long-acting 19-nor injectable; potent androgen with no aromatization. Simple model — peak calibrated.
Trenbolone Hexahydrobenzylcarbonate
Long-acting trenbolone (original Parabolan). Simple model — peak calibrated.
Testosterone Enanthate
Long-acting testosterone ester; the most common TRT and cycle base. Reaches steady state in ~5 weeks.
Protocols featuring Trenbolone Acetate
Comments
Loading comments…